Industry News
Pharmaceutical Industry News
Genentech’s chief marketing…
Genentech's chief marketing officer Zoë Lazarre, Ph.D., likens AI to a “armor, or a digital backpack” that her teams can use for better, faster insights, she said during an interview at Fierce Pharma Week.
Bristol Myers Squibb plans to lay…
Bristol Myers Squibb plans to lay off another 265 employees tied to its corporate headquarters in New Jersey, bringing the number of total job reductions the company has announced this year in the Garden State
As China and the U.S. presently…
As China and the U.S. presently duke it out over biopharma innovation supremacy, a clutch of Europe’s biggest drugmakers are calling on the bloc to not lose sight of its R&D roots.
Eric Dube, Ph.D., the CEO who…
Eric Dube, Ph.D., the CEO who rebranded Travere Therapeutics and oversaw the launch of its rare kidney disease drug Filspari, will step down to “focus on his health and family.” Bradley Campbell, formerly CEO of
Book Review: ‘The Age of Cures,’ by Barry Werth
In “The Age of Cures,” the journalist Barry Werth shows how American drug manufacturers got big and then came under attack.
Par Health issued a voluntary…
Par Health issued a voluntary recall of two lots of the IV sedative dexmedetomidine HCl in 0.9% sodium chloride injection that may be contaminated with cellulose or stopper material.
One in three women in the U.K….
One in three women in the U.K. feel their migraine pain “is taken less seriously by others because of their gender.”
The president announced plans to…
The president announced plans to split some childhood immunizations in the U.S. into five separate shots, given as “20% doses” every six months. The decision has garnered significant backlash from the medical community.
As Johnson & Johnson’s $14.6…
As Johnson & Johnson’s $14.6 billion bet on Intra-Cellular Therapies continues to pay off with blockbuster sales of Caplyta, the atypical antipsychotic has passed a phase 3 test that puts it one step closer to
Amid lawmaker and advocacy group…
Amid lawmaker and advocacy group efforts to parse the White House’s “most favored nation” drug pricing deals with drugmakers, newly revealed—yet heavily redacted—information is reigniting concerns about just who exactly the Trump administration policy benefits.
IntraBio’s streak of success in…
IntraBio's streak of success in the rare neurological category continues, as the drugmaker racks up a second indication for Aqneursa, now the first treatment in the world indicated for a rare ataxia.
With reports leaking out…
With reports leaking out of investor discontent, CEO Mike Doustdar opened Novo's Capital Markets Day by acknowledging that the company’s leadership “have to convince” the audience that “there is a bright future for Novo.”
Bayer has decided to offload its…
Bayer has decided to offload its aging cancer drug Stivarga to German compatriot Grünenthal as a potential new competitor from Exelixis nears an FDA decision.
Trump Promotes Program to Reduce Medicaid Drug Prices
Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
Journalist-turned-menopause…
Journalist-turned-menopause advocate Tamsen Fadal is using her storytelling skills to bring overlooked menopause conversations into the mainstream.
With longer progression-free…
With longer progression-free survival, Jake Van Naarden, president of Lilly Oncology, told Fierce he expects most patients to choose the combination over oral SERD monotherapy.
U.S. Women Seeking Hormone-Free IUDs Come Up Short
More patients want nonhormonal methods of birth control. Yet only one copper IUD is currently available in the United States.
With many of the healthcare…
With many of the healthcare industry’s top marketing minds converging in the City of Brotherly Love this past week, the galvanizing power of humor, authenticity and a little outside-of-the-box thinking in an ever-changing consumer landscape
The CHMP recommendation for Novo’s…
The CHMP recommendation for Novo's next gen hemophilia A treatment was one of several noteworthy endorsements made by the EU agency this week.